Product NDC: | 21695-186 |
Proprietary Name: | Sulfacetamide Sodium and Prednisolone Sodium Phosphate |
Non Proprietary Name: | sulfacetamide sodium and prednisolone sodium phosphate |
Active Ingredient(s): | 2.5; 100 mg/mL; mg/mL & nbsp; sulfacetamide sodium and prednisolone sodium phosphate |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 21695-186 |
Labeler Name: | Rebel Distributors Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074449 |
Marketing Category: | ANDA |
Start Marketing Date: | 19951229 |
Package NDC: | 21695-186-05 |
Package Description: | 5 mL in 1 BOTTLE (21695-186-05) |
NDC Code | 21695-186-05 |
Proprietary Name | Sulfacetamide Sodium and Prednisolone Sodium Phosphate |
Package Description | 5 mL in 1 BOTTLE (21695-186-05) |
Product NDC | 21695-186 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | sulfacetamide sodium and prednisolone sodium phosphate |
Dosage Form Name | SOLUTION |
Route Name | OPHTHALMIC |
Start Marketing Date | 19951229 |
Marketing Category Name | ANDA |
Labeler Name | Rebel Distributors Corp |
Substance Name | PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM |
Strength Number | 2.5; 100 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes | Sulfonamide Antibacterial [EPC],Sulfonamides [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |